Literature DB >> 22028435

Acute bacterial skin and skin structure infection trials: the bad is the enemy of the good.

Brad Spellberg.   

Abstract

Mesh：

Year:  2011        PMID： 22028435     DOI： 10.1093/cid/cir741

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  The FDA reboot of antibiotic development.

Authors:  David M Shlaes; Dan Sahm; Carol Opiela; Brad Spellberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

2.  Impact of hospital variables on case mix index as a marker of disease severity.

Authors:  Carmen M Mendez; Darrell W Harrington; Peter Christenson; Brad Spellberg
Journal:  Popul Health Manag       Date:  2013-08-21       Impact factor: 2.459

3.  Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.

Authors:  Jordan E Cates; Fanny S Mitrani-Gold; Gang Li; Linda M Mundy
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

Review 4.  The future of antibiotics.

Authors:  Brad Spellberg
Journal:  Crit Care       Date:  2014-06-27       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.